Overview
Moran Margolin-Livne practices practicing medicine in Jaffa, Israel.
His clinical expertise encompasses Leukocytosis, Gastrointestinal Bleeding, and Crohn's Disease.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Moran Margolin-Livne
Is Moran Margolin-Livne a top-rated expert for Leukocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Moran Margolin-Livne is classified as an Experienced expert for Leukocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Moran Margolin-Livne participate in research or clinical trials?
Yes. Moran Margolin-Livne has published 8 articles and abstracts on conditions like Leukocytosis. You can view a list of Moran Margolin-Livne's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Crohn's DiseaseMr. Margolin-Livne isExperienced. Learn about Crohn's Disease.
- Gastrointestinal BleedingMr. Margolin-Livne isExperienced. Learn about Gastrointestinal Bleeding.
- LeukocytosisMr. Margolin-Livne isExperienced. Learn about Leukocytosis.